Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)
ID: 346659Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/346659

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-110.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Biomedical Technology Optimization and Dissemination (BTOD) Centers, aimed at enhancing late-stage technologies crucial for biomedical research. This initiative encourages applications from a diverse range of eligible institutions, including higher education and nonprofit organizations, to optimize proven technologies and disseminate these advancements to the broader research community. The program emphasizes collaborative technology optimization projects, community engagement strategies, and the creation of self-sustaining technologies that meet the needs of biomedical researchers. Interested applicants should note that the application deadline is January 27, 2026, and can find further details and guidelines in the full announcement available at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-110-Full-Announcement.html
    PAR-23-110.html
    The Department of Health and Human Services' funding opportunity announcement (FOA) outlines a program for the establishment of Biomedical Technology Optimization and Dissemination (BTOD) Centers, aimed at enhancing late-stage technologies essential for biomedical research. This FOA encourages applications from various eligible institutions, including higher education and nonprofit organizations. Successful applicants will focus on optimizing technologies proven effective in lab settings and disseminating these improvements to the broader research community to facilitate independent use. Key features of the BTOD Centers include collaborative technology optimization (TOP) projects, driving biomedical projects (DBPs), and community engagement strategies aimed at training users and promoting widespread adoption of the technologies developed. Each center is expected to have a maximum funding period of 15 years and must demonstrate diversity and inclusivity through a Plan for Enhancing Diverse Perspectives. The FOA emphasizes adherence to application guidelines and submission requirements, including assurances of compliance with data management and sharing policies. Ultimately, the program seeks to create self-sustaining technologies that meet the needs of a broad spectrum of biomedical researchers while fostering innovation and broad accessibility to optimized tools. This initiative reflects the NIH's commitment to advancing scientific research through collaborative and inclusive approaches.
    Similar Opportunities
    Biomedical Technology Optimization and Dissemination Center (BTOD)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity for the Biomedical Technology Optimization and Dissemination Center (BTOD) program, aimed at optimizing late-stage biomedical technologies that have shown laboratory feasibility. The program's objective is to advance these technologies to a point of widespread use and promote their dissemination within the biomedical research community. This initiative is crucial for enhancing the application of innovative biomedical solutions, thereby contributing to advancements in health research. Interested applicants, including Indian/Native American Tribal Governments, eligible federal agencies, and community-based organizations, can reach out to Dr. Carolina Salvador Morales at carolina.salvadormorales@nih.gov or by phone at 301-480-0779 for further details. The estimated project start date is April 1, 2027, with a synopsis close date projected for May 28, 2026.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
    Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for exploratory research grants (R21) aimed at developing innovative technologies in biomedical research. This initiative seeks applications that propose high-risk, high-reward projects focused on technology development without existing proof of concept, specifically excluding clinical trials. The funding amount is capped at $275,000 in direct costs over two years, with a maximum of $200,000 available in any single year. Interested applicants, including higher education institutions and nonprofit organizations, must adhere to submission guidelines and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The application deadline is January 7, 2028.
    Funding Opportunity Announcement - NIBIB Technology Development Networks
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the NIBIB Technology Development Networks, aimed at establishing Coordinating Centers that will facilitate collaboration among scientific and engineering communities to address translational challenges in health technology development. These centers will enhance integration across various technology development projects, disseminate program advancements, and manage an Opportunity Funds program to support promising small-scale initiatives. With an estimated total program funding of $1 million and a projected award ceiling of $1 million, this cooperative agreement is expected to yield one award, with applications not currently being solicited. Interested parties are encouraged to prepare for future submissions, with key dates including an estimated synopsis post date of May 1, 2026, and an estimated award date of April 1, 2027. For further inquiries, potential applicants can contact Luisa Russell via email at luisa.russell@nih.gov.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research partnerships between academic and industrial investigators to accelerate the development of innovative bioengineering tools and technologies. The program seeks to establish multidisciplinary teams that apply a quantitative bioengineering approach to address significant biomedical challenges, with a focus on creating robust solutions that can enhance life science understanding and medical practices within a 5-10 year timeframe. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and for-profit entities, particularly those emphasizing diversity in research. Interested parties should note that the application deadline is September 7, 2027, and for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-325.html.
    Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)" aimed at supporting innovative research in the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. This cooperative agreement program encourages investigators to conduct translational activities and clinical feasibility studies, with a focus on advancing medical device technology through collaboration with NIH resources for design, testing, and regulatory support. The initiative is particularly significant as it seeks to accelerate the clinical introduction of medical technologies, ultimately improving patient outcomes while adhering to best practices in research and development. Interested applicants, including various eligible institutions and organizations, must submit their proposals by January 28, 2028, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for research focused on developing biomedical technologies that address health disparities. This initiative seeks to support projects that create effective, affordable, and socially acceptable technologies to improve healthcare access and outcomes for underserved populations. The estimated total program funding for this opportunity is $1,200,000, with an expected two awards to be made, and the application process is anticipated to open in late 2025. Interested applicants can reach out to Nichole Daringer at nichole.daringer@nih.gov or call 301-451-4774 for further information.
    BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System," aimed at enhancing technologies for recording neural activity and addressing significant challenges in neuroscience research. This initiative seeks applications focused on optimizing existing or emerging technologies through iterative testing with end users, with the goal of improving network recording capabilities and developing tools for circuit manipulation that can be validated in vivo. The funding, anticipated at $10 million per year for 15-20 awards, requires applicants to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research, with submissions due by January 20, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities" aimed at enhancing research capacity and innovation in bioengineering and biomedical imaging at HBCUs. This initiative aligns with the HBCU PARTNERS Act and seeks to foster collaborations that promote scientific growth and competitiveness in federal research funding. The estimated total program funding is $1,920,000, with four awards anticipated, and interested applicants are encouraged to prepare their proposals ahead of the expected synopsis posting on March 10, 2026, with applications due by June 1, 2026. For further inquiries, potential applicants can contact David Gutekunst, PhD, via email at dave.gutekunst@nih.gov.